| Previous Close | 3.65 |
| Open | 3.70 |
| Bid | 3.70 x 2700 |
| Ask | 3.75 x 3500 |
| Day's Range | 3.60 - 3.75 |
| 52 Week Range | 2.10 - 4.45 |
| Volume | 10,196 |
| Avg. Volume | 30,900 |
| Market Cap | 89.27M |
| Beta | N/A |
| PE Ratio (TTM) | -1.61 |
| EPS (TTM) | -2.33 |
| Earnings Date | Aug 8, 2017 - Aug 14, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 76.00 |
- GlobeNewswire•28 days ago
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
SAN DIEGO, May 31, 2017-- aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the Company's ...
- GlobeNewswire•last month
aTyr Pharma Announces Presentations on Interstitial Lung Disease and the iMod.Fc Program at the American Thoracic Society 2017 International Conference and Will Host an Educational Webinar
-Poster Presentations to Explore Potential of Augmenting Resokine Pathway in Severe, Rare Pulmonary Diseases with an Immune or Fibrotic Component-. -Conference Call and Webcast Featuring Guest Speaker ...
- Associated Press•2 months ago
Atyr Pharma reports 1Q loss
The San Diego-based company said it had a loss of 56 cents per share. In the final minutes of trading on Thursday, the company's shares hit $3.10. A year ago, they were trading at $3.01. _____ This story ...